News

Shaklee Expands Product Range with Modere Acquisition Highlights

Shaklee Expands Product Range with Modere Acquisition Highlights

Shaklee's Strategic Acquisition of Modere

Shaklee, a renowned leader in the nutrition supplement sector, has taken a significant step forward by acquiring nearly all operations of Modere through a subsidiary. This bold move includes Modere's comprehensive portfolio of trademarks, patents, and product formulas, notably featuring the celebrated Liquid BioCell® Collagen and Trim collections. The acquisition also encompasses all manufacturing and testing apparatus within Modere's North American facilities, alongside current inventories which feature key products such as Liquid BioCell®, Trim, Burn, Sculpt, and Curb.

Continuity and Innovation with Trusted Products

With this acquisition, Shaklee has secured an exclusive license to sell Liquid BioCell® Collagen under its trusted brand. Customers can expect the same high-quality collagen products they’ve enjoyed, now infused with the reliability and excellence that Shaklee guarantees. Roger Barnett, Shaklee's Chairman and CEO, expressed excitement about this acquisition, emphasizing the opportunity it presents to provide proven products to the myriad of consumers who appreciate the benefits they bring.

Empowering Former Modere Social Marketers

Alongside expanding Shaklee's product range, the company is thrilled to welcome the previous Modere Social Marketers into its community. This initiative aims to foster a collaborative environment where these individuals can share their commitment to promoting healthier lifestyles. Barnett highlighted the importance of this move to support their continued passion for wellness.

Availability of New Product Lines

All newly acquired products will be readily accessible through Shaklee's extensive network of ambassadors as well as on Shaklee’s official website. Starting from the last week of May, consumers can purchase popular items such as Liquid BioCell® Collagen, Trim, Sculpt, Burn, and Curb. This rollout marks a significant development in Shaklee’s ongoing mission to lead in the wellness sector.

A Legacy of Wellness and Sustainability

Shaklee's commitment to wellness innovation is deep-rooted, dating back to its founder, Dr. Shaklee, who revolutionized multivitamins in the U.S. over a century ago. The company has also been a trailblazer in sustainability, notably being the first global company to offset its carbon emissions completely, ensuring a net zero environmental impact. Shaklee’s products are thoroughly backed by over 110 published clinical studies which validate their safety and effectiveness.

Healthier Living for All

Currently, Shaklee markets its comprehensive range of products through over 2 million dedicated ambassadors across North America and Asia. This expansive network ensures that Shaklee can deliver vital wellness support to those seeking to enhance their quality of life. Remaining steadfast in their commitment to health, Shaklee aspires to inspire consumers to feel and look their best, enhancing vitality for years to come.

Frequently Asked Questions

What recent acquisition did Shaklee announce?

Shaklee announced its acquisition of nearly all of Modere's operations, including popular products like Liquid BioCell® Collagen and Trim.

When will the new products be available for purchase?

The new products will be available for purchase starting in the last week of May through Shaklee's ambassadors and website.

What is Shaklee's legacy in the wellness industry?

Shaklee was founded over 100 years ago by Dr. Shaklee, known for inventing the first multivitamin in the U.S. and committing to sustainability.

How does Shaklee ensure the quality of its products?

Shaklee products are backed by more than 110 published clinical studies that affirm their safety and efficacy.

What support does Shaklee provide to former Modere Social Marketers?

Shaklee welcomes former Modere Social Marketers to join its community, fostering an environment for them to promote health and wellness.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Perrigo's Reinvention Strategy: A Path to Sustainable Success

Updated Category News Views 152

Perrigo Restructures for Future Growth and Performance Perrigo Company plc (NYSE: PRGO), a recognized leader in the consumer self-care products industry, has embarked on an ambitious path of organizational realignment aimed at ensuring sustainable growth and enhanced operational performance. This strategic initiative is expected to bolster agility and innovation within...

Continue Reading
Eli Lilly Prepares for Weight-Loss Drug Launch Amid FDA Review

Updated Category News Views 225

Eli Lilly's Strategic Inventory Build-Up Eli Lilly and Company (NYSE: LLY) has made headlines recently by accumulating an impressive $1.5 billion worth of inventory for its experimental oral weight-loss pill, orforglipron. This move comes in light of the anticipated decision by the FDA, which could take place in the near future. The increase in inventory value represents...

Continue Reading
Roblox's CFO Transition: Leadership Change and Future Prospects

Updated Category News Views 352

Roblox Corporation Announces CFO Transition Roblox Corporation (NYSE:RBLX) has recently made headlines as its Chief Financial Officer, Michael Guthrie, prepares to leave his post to focus on personal pursuits. This change reflects a significant moment in the company's leadership dynamics, with the announcement stemming from a formal Separation and Transition Agreement....

Continue Reading
MaxCyte's 2024 Financial Results Highlight Growth and Innovation

Updated Category News Views 149

MaxCyte Reports Positive Financial Results for 2024 MaxCyte, Inc. (NASDAQ: MXCT; LSE: MXCT), a renowned company at the forefront of cell engineering, has shared exciting preliminary financial outcomes for its fourth quarter and the entire year of 2024. These results demonstrate steady growth in revenue and a stronger position in the rapidly evolving cell therapy industry....

Continue Reading
XORTX Therapeutics Invites Shareholders to Participate Actively

Updated Category News Views 113

XORTX Therapeutics Encourages Shareholder Participation CALGARY, Alberta – XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a leading clinical pharmaceutical company focused on developing innovative therapies for progressive kidney disease, is reaching out to its shareholders. They want to remind everyone about the important voting deadline for the...

Continue Reading